Kasten M J
Division of Infectious Diseases and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905, USA.
Mayo Clin Proc. 1999 Aug;74(8):825-33. doi: 10.4065/74.8.825.
Clindamycin, metronidazole, and chloramphenicol are three antimicrobial agents useful in the treatment of anaerobic infections. Clindamycin is effective in the treatment of most infections involving anaerobes and gram-positive cocci, but emerging resistance has become a problem in some clinical settings. Metronidazole is effective in the treatment of infections involving gram-negative anaerobes, but it is unreliable in the treatment of gram-positive anaerobic infections and is ineffective in treating aerobic infections. Additionally, metronidazole is often the drug of choice in treating infections in which Bacteroides fragilis is a serious concern. Chloramphenicol is effective in the treatment of a wide variety of bacterial infections, including serious anaerobic infections, but is rarely used in Western countries because of concerns about toxicity, including aplastic anemia and gray baby syndrome.
克林霉素、甲硝唑和氯霉素是三种可用于治疗厌氧菌感染的抗菌药物。克林霉素对大多数涉及厌氧菌和革兰氏阳性球菌的感染有效,但在某些临床环境中,新出现的耐药性已成为一个问题。甲硝唑对涉及革兰氏阴性厌氧菌的感染有效,但对革兰氏阳性厌氧菌感染的治疗不可靠,对需氧菌感染无效。此外,甲硝唑通常是治疗脆弱拟杆菌感染的首选药物。氯霉素对多种细菌感染有效,包括严重的厌氧菌感染,但由于担心其毒性,包括再生障碍性贫血和灰婴综合征,在西方国家很少使用。